{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:25:59Z","timestamp":1791476759243,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr Metab (Lond)"],"DOI":"10.1186\/s12986-025-01002-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:50:40Z","timestamp":1759236640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Probiotics and inflammatory bowel disease: an umbrella meta-analysis of relapse, recurrence, and remission outcomes"],"prefix":"10.1186","volume":"22","author":[{"given":"Wei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranasadat","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Saedisomeolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1002_CR1","doi-asserted-by":"publisher","first-page":"1103713","DOI":"10.3389\/fped.2022.1103713","volume":"10","author":"SM Borowitz","year":"2023","unstructured":"Borowitz SM. The epidemiology of inflammatory bowel disease: clues to pathogenesis? Front Pead. 2023;10:1103713.","journal-title":"Front Pead"},{"key":"1002_CR2","doi-asserted-by":"publisher","first-page":"844961","DOI":"10.3389\/fphar.2022.844961","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Ye Z, She Y, Li L, Wu M, Qin K, Li Y, He H, Hu Z, Yang M. Efficacy and safety of probiotics combined with traditional Chinese medicine for ulcerative colitis: A systematic review and meta-analysis. Front Pharmacol. 2022;13:844961.","journal-title":"Front Pharmacol"},{"key":"1002_CR3","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/j.cgh.2022.06.030","volume":"21","author":"MJ Buie","year":"2023","unstructured":"Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, Kotze PG, Gearry RB, Ng SC, Mak JWY, et al. Global hospitalization trends for crohn\u2019s disease and ulcerative colitis in the 21st century: A systematic review with Temporal analyses. Clin Gastroenterol Hepatol. 2023;21:2211\u201321.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1002_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/09637486.2018.1477123","volume":"70","author":"AY Coqueiro","year":"2019","unstructured":"Coqueiro AY, Raizel R, Bonvini A, Tirapegui J, Rogero MM. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment. Int J Food Sci Nutr. 2019;70:20\u20139.","journal-title":"Int J Food Sci Nutr"},{"key":"1002_CR5","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med. 2021;8:765474.","journal-title":"Front Med"},{"key":"1002_CR6","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1007\/s00394-021-02503-5","volume":"60","author":"XF Zhang","year":"2021","unstructured":"Zhang XF, Guan XX, Tang YJ, Sun JF, Wang XK, Wang WD, Fan JM. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. Eur J Nutr. 2021;60:2855\u201375.","journal-title":"Eur J Nutr"},{"key":"1002_CR7","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/jcp.25911","volume":"233","author":"M Ganji-Arjenaki","year":"2018","unstructured":"Ganji-Arjenaki M, Rafieian\u2010Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2018;233:2091\u2013103.","journal-title":"J Cell Physiol"},{"key":"1002_CR8","doi-asserted-by":"publisher","first-page":"1215329","DOI":"10.3389\/fimmu.2023.1215329","volume":"14","author":"AG Gravina","year":"2023","unstructured":"Gravina AG, Pellegrino R, Palladino G, Coppola A, Brandimarte G, Tuccillo C, Ciardiello F, Romano M, Federico A. Hericium erinaceus, in combination with natural flavonoid\/alkaloid and B(3)\/B(8) vitamins, can improve inflammatory burden in inflammatory bowel diseases tissue: an ex vivo study. Front Immunol. 2023;14:1215329.","journal-title":"Front Immunol"},{"key":"1002_CR9","first-page":"20866","volume":"9","author":"X Peng","year":"2016","unstructured":"Peng X, Zhang J, Ji M, Jiasong, Dong W, Liu W. Effect of probiotic for maintenance of remission in adult ulcerative colitis: a meta-analysis. Int J Clin Exp Med. 2016;9:20866\u201374.","journal-title":"Int J Clin Exp Med"},{"key":"1002_CR10","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.3390\/nu12092628","volume":"12","author":"M Pab\u00f3n-Carrasco","year":"2020","unstructured":"Pab\u00f3n-Carrasco M, Ramirez-Baena L, Vilar-Palomo S, Castro-M\u00e9ndez A, Martos-Garc\u00eda R, Rodr\u00edguez-Gallego I. Probiotics as a coadjuvant factor in active or quiescent inflammatory bowel disease of adults\u2014A meta-analytical study. Nutrients. 2020;12:2628.","journal-title":"Nutrients"},{"key":"1002_CR11","doi-asserted-by":"publisher","first-page":"BSR20180943","DOI":"10.1042\/BSR20180943","volume":"39","author":"L Peng","year":"2019","unstructured":"Peng L, Zhong Y, Wang A, Jiang Z. Probiotics combined with Aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial. Biosci Rep. 2019;39:BSR20180943.","journal-title":"Biosci Rep"},{"key":"1002_CR12","first-page":"7540","volume":"11","author":"C Lin","year":"2018","unstructured":"Lin C, Ma L, Lin J, Li C. Meta-analysis of the safety and efficacy of probiotics in the treatment of crohn\u2019s disease. Int J Clin Exp Med. 2018;11:7540\u20137.","journal-title":"Int J Clin Exp Med"},{"key":"1002_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1365-2036.2010.04231.x","volume":"31","author":"G Doherty","year":"2010","unstructured":"Doherty G, Bennett G, Cheifetz A, Moss A. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post\u2010operative crohn\u2019s disease. Aliment Pharmacol Ther. 2010;31:802\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1002_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-013-0440-8","volume":"7","author":"M Fujiya","year":"2014","unstructured":"Fujiya M, Ueno N, Kohgo Y. Probiotic treatments for induction and maintenance of remission in inflammatory bowel diseases: a meta-analysis of randomized controlled trials. Clin J Gastroenterol. 2014;7:1\u201313.","journal-title":"Clin J Gastroenterol"},{"key":"1002_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Reviews. 2015;4:1\u20139.","journal-title":"Syst Reviews"},{"key":"1002_CR16","doi-asserted-by":"crossref","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. bmj 2017, 358.","DOI":"10.1136\/bmj.j4008"},{"key":"1002_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"1002_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1002_CR19","doi-asserted-by":"crossref","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994:1088\u2013101.","DOI":"10.2307\/2533446"},{"key":"1002_CR20","first-page":"Cd007443","volume":"3","author":"Z Iheozor-Ejiofor","year":"2020","unstructured":"Iheozor-Ejiofor Z, Kaur L, Gordon M, Baines PA, Sinopoulou V, Akobeng AK. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020;3:Cd007443.","journal-title":"Cochrane Database Syst Rev"},{"key":"1002_CR21","doi-asserted-by":"publisher","first-page":"e13792","DOI":"10.1097\/MD.0000000000013792","volume":"97","author":"K Jia","year":"2018","unstructured":"Jia K, Tong X, Wang R, Song X. The clinical effects of probiotics for inflammatory bowel disease: A meta-analysis. Med (Baltim). 2018;97:e13792.","journal-title":"Med (Baltim)"},{"key":"1002_CR22","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3748\/wjg.v16.i15.1908","volume":"16","author":"LX Sang","year":"2010","unstructured":"Sang LX, Chang B, Zhang WL, Wu XM, Li XH, Jiang M. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis. World J Gastroenterol. 2010;16:1908\u201315.","journal-title":"World J Gastroenterol"},{"key":"1002_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1445-5994.2008.01791.x","volume":"39","author":"J Shen","year":"2009","unstructured":"Shen J, Ran HZ, Yin MH, Zhou TX, Xiao DS. Meta-analysis: the effect and adverse events of lactobacilli versus placebo in maintenance therapy for Crohn disease. Intern Med J. 2009;39:103\u20139.","journal-title":"Intern Med J"},{"key":"1002_CR24","first-page":"185","volume":"4","author":"R Rahimi","year":"2008","unstructured":"Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission. Archives Med Sci. 2008;4:185\u201390.","journal-title":"Archives Med Sci"},{"key":"1002_CR25","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.21037\/apm-21-2996","volume":"10","author":"M Chen","year":"2021","unstructured":"Chen M, Feng Y, Liu W. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis. Ann Palliat Med. 2021;10:11821\u20139.","journal-title":"Ann Palliat Med"},{"key":"1002_CR26","doi-asserted-by":"crossref","unstructured":"Pab\u00f3n-Carrasco M, Ramirez-Baena L, Vilar-Palomo S, Castro-M\u00e9ndez A, Martos-Garc\u00eda R, Rodr\u00edguez-Gallego I. Probiotics as a coadjuvant factor in active or quiescent inflammatory bowel disease of Adults-A Meta-Analytical study. Nutrients 2020, 12.","DOI":"10.3390\/nu12092628"},{"key":"1002_CR27","first-page":"Cd006634","volume":"7","author":"BN Limketkai","year":"2020","unstructured":"Limketkai BN, Akobeng AK, Gordon M, Adepoju AA. Probiotics for induction of remission in crohn\u2019s disease. Cochrane Database Syst Rev. 2020;7:Cd006634.","journal-title":"Cochrane Database Syst Rev"},{"key":"1002_CR28","doi-asserted-by":"crossref","unstructured":"Peng L, Zhong Y, Wang A, Jiang Z. Probiotics combined with Aminosalicylic acid affiliates remission of ulcerative colitis: a meta-analysis of randomized controlled trial. Biosci Rep 2019, 39.","DOI":"10.1042\/BSR20180943"},{"key":"1002_CR29","doi-asserted-by":"crossref","unstructured":"Ast\u00f3 E, M\u00e9ndez I, Audivert S, Farran-Codina A, Espadaler J. The efficacy of probiotics, prebiotic Inulin-Type fructans, and synbiotics in human ulcerative colitis: A systematic review and Meta-Analysis. Nutrients 2019, 11.","DOI":"10.3390\/nu11020293"},{"key":"1002_CR30","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/jcp.25911","volume":"233","author":"M Ganji-Arjenaki","year":"2018","unstructured":"Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol. 2018;233:2091\u2013103.","journal-title":"J Cell Physiol"},{"key":"1002_CR31","doi-asserted-by":"publisher","first-page":"844961","DOI":"10.3389\/fphar.2022.844961","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Ye Z, She Y, Li L, Wu M, Qin K, Li Y, He H, Hu Z, Yang M, et al. Efficacy and safety of probiotics combined with traditional Chinese medicine for ulcerative colitis: A systematic review and Meta-Analysis. Front Pharmacol. 2022;13:844961.","journal-title":"Front Pharmacol"},{"key":"1002_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/j.1365-2036.2010.04231.x","volume":"31","author":"GA Doherty","year":"2010","unstructured":"Doherty GA, Bennett GC, Cheifetz AS, Moss AC. Meta-analysis: targeting the intestinal microbiota in prophylaxis for post-operative crohn\u2019s disease. Aliment Pharmacol Ther. 2010;31:802\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1002_CR33","doi-asserted-by":"crossref","unstructured":"Dore MP, Bibb\u00f2 S, Fresi G, Bassotti G, Pes GM. Side effects associated with probiotic use in adult patients with inflammatory bowel disease: A systematic review and Meta-Analysis of randomized controlled trials. Nutrients 2019, 11.","DOI":"10.3390\/nu11122913"},{"key":"1002_CR34","doi-asserted-by":"publisher","first-page":"961","DOI":"10.12998\/wjcc.v6.i15.961","volume":"6","author":"G Sohail","year":"2018","unstructured":"Sohail G, Xu X, Christman MC, Tompkins TA. Probiotic Medilac-S(\u00ae) for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World J Clin Cases. 2018;6:961\u201384.","journal-title":"World J Clin Cases"},{"key":"1002_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/apt.14203","volume":"46","author":"Y Derwa","year":"2017","unstructured":"Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:389\u2013400.","journal-title":"Aliment Pharmacol Ther"},{"key":"1002_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/jrsm.1658","volume":"14","author":"M Kirvalidze","year":"2023","unstructured":"Kirvalidze M, Abbadi A, Dahlberg L, Sacco LB, Calder\u00f3n-Larra\u00f1aga A, Morin L. Estimating pairwise overlap in umbrella reviews: considerations for using the corrected covered area (CCA) index methodology. Res Synth Methods. 2023;14:764\u20137.","journal-title":"Res Synth Methods"},{"key":"1002_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jrsm.1557","volume":"13","author":"J P\u00e9rez-Bracchiglione","year":"2022","unstructured":"P\u00e9rez-Bracchiglione J, Meza N, Bangdiwala SI, Ni\u00f1o de Guzm\u00e1n E, Urr\u00fatia G, Bonfill X, Madrid E. Graphical representation of overlap for overviews: GROOVE tool. Res Synth Methods. 2022;13:381\u20138.","journal-title":"Res Synth Methods"},{"key":"1002_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0895-4356(99)00161-4","volume":"53","author":"A Thornton","year":"2000","unstructured":"Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol. 2000;53:207\u201316.","journal-title":"J Clin Epidemiol"},{"key":"1002_CR39","doi-asserted-by":"publisher","first-page":"961","DOI":"10.12998\/wjcc.v6.i15.961","volume":"6","author":"G Sohail","year":"2018","unstructured":"Sohail G, Xu X, Christman MC, Tompkins TA. Probiotic Medilac-S\u00ae for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World J Clin Cases. 2018;6:961.","journal-title":"World J Clin Cases"},{"key":"1002_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/apt.14203","volume":"46","author":"Y Derwa","year":"2017","unstructured":"Derwa Y, Gracie D, Hamlin P, Ford A. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:389\u2013400.","journal-title":"Aliment Pharmacol Ther"},{"key":"1002_CR41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.5217\/ir.2018.00073","volume":"16","author":"S Danese","year":"2018","unstructured":"Danese S, Banerjee R, Cummings JF, Dotan I, Kotze PG, Leong RWL, Paridaens K, Peyrin-Biroulet L, Scott G, Assche GV. Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i support Therapy-Access to rapid treatment (iSTART) approach. Intest Res. 2018;16:522\u20138.","journal-title":"Intest Res"},{"key":"1002_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.diagmicrobio.2012.11.022","volume":"75","author":"S Sha","year":"2013","unstructured":"Sha S, Xu B, Wang X, Zhang Y, Wang H, Kong X, Zhu H, Wu K. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn Microbiol Infect Dis. 2013;75:245\u201351.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1002_CR43","first-page":"55","volume":"16","author":"M Stojan\u010devi\u0107","year":"2014","unstructured":"Stojan\u010devi\u0107 M, Boji\u0107 G, Al Salami H, Mikov M. The influence of intestinal tract and probiotics on the fate of orally administered drugs. Curr Issues Mol Biol. 2014;16:55\u201368.","journal-title":"Curr Issues Mol Biol"},{"key":"1002_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jsps.2012.03.005","volume":"20","author":"YN Gavhane","year":"2012","unstructured":"Gavhane YN, Yadav AV. Loss of orally administered drugs in GI tract. Saudi Pharm J. 2012;20:331\u201344.","journal-title":"Saudi Pharm J"},{"key":"1002_CR45","first-page":"375","volume":"89","author":"EF Enright","year":"2016","unstructured":"Enright EF, Gahan CG, Joyce SA, Griffin BT. Focus: microbiome: the impact of the gut microbiota on drug metabolism and clinical outcome. Yale J Biol Med. 2016;89:375.","journal-title":"Yale J Biol Med"},{"key":"1002_CR46","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/bph.13571","volume":"174","author":"A Ryan","year":"2017","unstructured":"Ryan A. Azoreductases in drug metabolism. Br J Pharmacol. 2017;174:2161\u201373.","journal-title":"Br J Pharmacol"},{"key":"1002_CR47","doi-asserted-by":"publisher","first-page":"5432","DOI":"10.1128\/JB.186.16.5432-5441.2004","volume":"186","author":"L Grozdanov","year":"2004","unstructured":"Grozdanov L, Raasch C, Schulze U Jr, Gottschalk G, Hacker U Jr. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol. 2004;186:5432\u201341.","journal-title":"J Bacteriol"},{"key":"1002_CR48","doi-asserted-by":"crossref","unstructured":"Jia K, Tong X, Wang R, Song X. The clinical effects of probiotics for inflammatory bowel disease: A meta-analysis. Medicine 2018, 97.","DOI":"10.1097\/MD.0000000000013792"},{"key":"1002_CR49","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.3390\/ijms20205026","volume":"20","author":"F Cappello","year":"2019","unstructured":"Cappello F, Rappa F, Canepa F, Carini F, Mazzola M, Tomasello G, Bonaventura G, Giuliana G, Leone A, Saguto D. Probiotics can cure oral aphthous-like ulcers in inflammatory bowel disease patients: A review of the literature and a working hypothesis. Int J Mol Sci. 2019;20:5026.","journal-title":"Int J Mol Sci"},{"key":"1002_CR50","doi-asserted-by":"publisher","first-page":"e14302","DOI":"10.1111\/jfbc.14302","volume":"46","author":"Z Alam","year":"2022","unstructured":"Alam Z, Shang X, Effat K, Kanwal F, He X, Li Y, Xu C, Niu W, War AR, Zhang Y. The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer. J Food Biochem. 2022;46:e14302.","journal-title":"J Food Biochem"},{"key":"1002_CR51","doi-asserted-by":"publisher","first-page":"16189","DOI":"10.1038\/s41598-020-73292-w","volume":"10","author":"N Gupta","year":"2020","unstructured":"Gupta N, Ferreira J, Hong CHL, Tan KS. Lactobacillus reuteri DSM 17938 and ATCC PTA 5289 ameliorates chemotherapy-induced oral mucositis. Sci Rep. 2020;10:16189.","journal-title":"Sci Rep"},{"key":"1002_CR52","first-page":"5687","volume":"35","author":"D Scartoni","year":"2015","unstructured":"Scartoni D, Desideri I, Giacomelli I, Di Cataldo V, Di Brina L, Mancuso A, Furfaro I, Bonomo P, Simontacchi G, Livi L. Nutritional supplement based on zinc, prebiotics, probiotics and vitamins to prevent radiation-related Gastrointestinal disorders. Anticancer Res. 2015;35:5687\u201392.","journal-title":"Anticancer Res"},{"key":"1002_CR53","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.3390\/nu11102453","volume":"11","author":"M Molska","year":"2019","unstructured":"Molska M, Regu\u0142a J. Potential mechanisms of probiotics action in the prevention and treatment of colorectal cancer. Nutrients. 2019;11:2453.","journal-title":"Nutrients"},{"key":"1002_CR54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/19490976.2017.1284732","volume":"8","author":"F Imhann","year":"2017","unstructured":"Imhann F, Vich Vila A, Bonder MJ, Lopez Manosalva AG, Koonen DP, Fu J, Wijmenga C, Zhernakova A, Weersma RK. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017;8:351\u20138.","journal-title":"Gut Microbes"},{"key":"1002_CR55","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vila AV, Fu J, Mujagic Z, Vork L, Tigchelaar EF, Jankipersadsing SA, Cenit MC, Harmsen HJ. Proton pump inhibitors affect the gut Microbiome. Gut. 2016;65:740\u20138.","journal-title":"Gut"},{"key":"1002_CR56","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383:2652\u201364.","journal-title":"N Engl J Med"},{"key":"1002_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10400","volume":"477","author":"C G\u00fcnther","year":"2011","unstructured":"G\u00fcnther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, Waldner MJ, Hedrick SM, Tenzer S, Neurath MF. Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis. Nature. 2011;477:335\u20139.","journal-title":"Nature"},{"key":"1002_CR58","doi-asserted-by":"publisher","first-page":"59915","DOI":"10.18632\/oncotarget.18346","volume":"8","author":"Y-H Ding","year":"2017","unstructured":"Ding Y-H, Qian L-Y, Pang J, Lin J-Y, Xu Q, Wang L-H, Huang D-S, Zou H. The regulation of immune cells by lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy. Oncotarget. 2017;8:59915.","journal-title":"Oncotarget"},{"key":"1002_CR59","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jff.2013.11.006","volume":"6","author":"R Ashraf","year":"2014","unstructured":"Ashraf R, Vasiljevic T, Day SL, Smith SC, Donkor O. Lactic acid bacteria and probiotic organisms induce different cytokine profile and regulatory T cells mechanisms. J Funct Foods. 2014;6:395\u2013409.","journal-title":"J Funct Foods"},{"key":"1002_CR60","doi-asserted-by":"crossref","unstructured":"Liu D, Jiang X-Y, Zhou L-S, Song J-H, Zhang X. Effects of probiotics on intestinal mucosa barrier in patients with colorectal cancer after operation: meta-analysis of randomized controlled trials. Medicine 2016, 95.","DOI":"10.1097\/MD.0000000000003342"},{"key":"1002_CR61","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/nu5061869","volume":"5","author":"H Hardy","year":"2013","unstructured":"Hardy H, Harris J, Lyon E, Beal J, Foey AD. Probiotics, prebiotics and Immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients. 2013;5:1869\u2013912.","journal-title":"Nutrients"},{"key":"1002_CR62","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1189\/jlb.0611286","volume":"92","author":"D Ghadimi","year":"2012","unstructured":"Ghadimi D, Helwig U, Schrezenmeir J, Heller KJ, de Vrese M. Epigenetic imprinting by commensal probiotics inhibits the IL-23\/IL-17 axis in an in vitro model of the intestinal mucosal immune system. J Leukoc Biol. 2012;92:895\u2013911.","journal-title":"J Leukoc Biol"},{"key":"1002_CR63","doi-asserted-by":"crossref","unstructured":"Fernandez R, Sharifnia AM, Khalil H. Umbrella reviews: A methodological guide. Eur J Cardiovasc Nurs 2025.","DOI":"10.1093\/eurjcn\/zvaf012"},{"key":"1002_CR64","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","volume":"16","author":"T Raine","year":"2022","unstructured":"Raine T, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohns Colitis. 2022;16:2\u201317.","journal-title":"J Crohns Colitis"},{"key":"1002_CR65","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","volume":"158","author":"JD Feuerstein","year":"2020","unstructured":"Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology. 2020;158:1450\u201361.","journal-title":"Gastroenterology"}],"container-title":["Nutrition & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01002-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12986-025-01002-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12986-025-01002-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:09:32Z","timestamp":1759237772000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionandmetabolism.biomedcentral.com\/articles\/10.1186\/s12986-025-01002-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/s12986-025-01002-2","relation":{},"ISSN":["1743-7075"],"issn-type":[{"value":"1743-7075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}